DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Marksans Pharma Limited — Investor Presentation

NSE 57 min ago·12 Aug 2026, 7:00 am

Marksans Pharma

Marksans Pharma Limited has submitted an investor presentation to the stock exchanges, providing an update on its business performance and strategic outlook. This disclosure is a routine corporate governance practice that allows the company to communicate its current status directly to the market.

For investors, this update is significant as it offers a window into the company's management's view on its growth trajectory and operational health. It helps retail shareholders assess the firm's direction and compare it against market expectations before the next major earnings announcement.

Investors should focus on the management commentary regarding revenue growth, margin expansion, and the progress of key product launches. Keeping an eye on the forward-looking statements in the presentation will be crucial for understanding the company's future plans.